While we have detailed the various strengths and weaknesses of each analytical method, each requires careful calibration with appropriate standardization to ensure that results are of high quality
All treatment plans are personalized based on your medical history, goals, and clinical evaluation
Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide
Limit trigger foods: fried, greasy, sugary, dairy, sugar alcohols, caffeine, and alcohol
Human Growth Hormone (HGH) The human growth hormone (HGH) is produced by the pituitary gland and is a naturally occurring hormone important for growth, cell reproduction and cell regeneration
